Abstract
Synapsin I (Protein I), a neuron-specfic phosphoprotein enriched in presynaptic nerve terminals, has been used as a quantitative marker for the density of nerve terminals in five brain regions (caudate nucleus, cingulate gyrus, hippocampus, mesencephalon and putamen) from patients who had suffered from Alzheimer disease/senile dementia of Alzheimer type (AD/SDAT), from patients with multi-infarct dementia (MID), and from agematched controls. Samples were obtained at autopsy. Lower levels of Synapsin I were observed in the hippocampus of patients with AD/SDAT but not with MID. There were no significant differences in Synapsin I levels between patients and controls in any of the other four brain regions examined.
Adolfsson, R;
Alafuzoff, I;
Winblad, B;
[1]
Perdahl, E;
Albert, K A;
Nestler, E J;
Greengard, P
[2]
- Umeaa Univ. (Sweden)
- Rockefeller Univ., New York (USA)
Citation Formats
Adolfsson, R, Alafuzoff, I, Winblad, B, Perdahl, E, Albert, K A, Nestler, E J, and Greengard, P.
Synapsin I (Protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementia. [Radioimmunoassay].
Austria: N. p.,
1984.
Web.
Adolfsson, R, Alafuzoff, I, Winblad, B, Perdahl, E, Albert, K A, Nestler, E J, & Greengard, P.
Synapsin I (Protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementia. [Radioimmunoassay].
Austria.
Adolfsson, R, Alafuzoff, I, Winblad, B, Perdahl, E, Albert, K A, Nestler, E J, and Greengard, P.
1984.
"Synapsin I (Protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementia. [Radioimmunoassay]."
Austria.
@misc{etde_5863781,
title = {Synapsin I (Protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementia. [Radioimmunoassay]}
author = {Adolfsson, R, Alafuzoff, I, Winblad, B, Perdahl, E, Albert, K A, Nestler, E J, and Greengard, P}
abstractNote = {Synapsin I (Protein I), a neuron-specfic phosphoprotein enriched in presynaptic nerve terminals, has been used as a quantitative marker for the density of nerve terminals in five brain regions (caudate nucleus, cingulate gyrus, hippocampus, mesencephalon and putamen) from patients who had suffered from Alzheimer disease/senile dementia of Alzheimer type (AD/SDAT), from patients with multi-infarct dementia (MID), and from agematched controls. Samples were obtained at autopsy. Lower levels of Synapsin I were observed in the hippocampus of patients with AD/SDAT but not with MID. There were no significant differences in Synapsin I levels between patients and controls in any of the other four brain regions examined.}
journal = []
volume = {60:2}
journal type = {AC}
place = {Austria}
year = {1984}
month = {Jan}
}
title = {Synapsin I (Protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementia. [Radioimmunoassay]}
author = {Adolfsson, R, Alafuzoff, I, Winblad, B, Perdahl, E, Albert, K A, Nestler, E J, and Greengard, P}
abstractNote = {Synapsin I (Protein I), a neuron-specfic phosphoprotein enriched in presynaptic nerve terminals, has been used as a quantitative marker for the density of nerve terminals in five brain regions (caudate nucleus, cingulate gyrus, hippocampus, mesencephalon and putamen) from patients who had suffered from Alzheimer disease/senile dementia of Alzheimer type (AD/SDAT), from patients with multi-infarct dementia (MID), and from agematched controls. Samples were obtained at autopsy. Lower levels of Synapsin I were observed in the hippocampus of patients with AD/SDAT but not with MID. There were no significant differences in Synapsin I levels between patients and controls in any of the other four brain regions examined.}
journal = []
volume = {60:2}
journal type = {AC}
place = {Austria}
year = {1984}
month = {Jan}
}